Gefitinib

Gefitinib is a tyrosine kinase inhibitor used for non-small cell lung cancer treatment by inhibiting EGFR. It is grouped under the following drug class(es): Antineoplastic agents, Kinase inhibitors and Tyrosine Kinase Inhibitors. Its therapeutic use is listed as anti-cancer agents and antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Iressa and Irressat. Its PubChem CID is 123631.

CAS No 184475-35-2
Molecular Formula C22H24ClFNO3
Molecular Weight 446.90 g/mol
Synonyms N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine

Frequently Asked Questions